We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
MIMS Research Foundation, a research arm of Aster DM Healthcare is developing a polyclonal antibody to stop cytokine storm in coronavirus. The researchers aim to prevent coronavirus related deaths with the novel drug.